Cargando…

NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells

Development of resistance to therapy in ovarian cancer is a major hinderance for therapeutic efficacy; however, new mechanisms of the resistance remain to be elucidated. NADPH oxidase 4 (NOX4) is responsible for higher NADPH activity to increase reactive oxygen species (ROS) production. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wen-Jing, Huang, Ying-Xue, Wang, Wei, Zhang, Ye, Liu, Bing-Jie, Qiu, Jian-Ge, Jiang, Bing-Hua, Liu, Ling-Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304464/ https://www.ncbi.nlm.nih.gov/pubmed/34209278 http://dx.doi.org/10.3390/cells10071647

Ejemplares similares

ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance
por: Stieg, David C., et al.
Publicado: (2022)

Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis
por: Li, Ji-Lin, et al.
Publicado: (2019)

Overexpression of HER2/HER3 and clinical feature of ovarian cancer
por: Chung, Ye Won, et al.
Publicado: (2019)

NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling
por: Zhang, Cuixiang, et al.
Publicado: (2014)

Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke
por: Liu, Wenlan, et al.
Publicado: (2011)

microRNA-497 slows esophageal cancer development and reverses chemotherapy resistance through its target QKI
por: Xie, Yun-Xia, et al.
Publicado: (2023)

MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1
por: Wang, Lin, et al.
Publicado: (2021)

Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
por: Liu, Xiaolong, et al.
Publicado: (2019)

NOX4-derived ROS Regulates Aerobic Glycolysis of Breast Cancer through YAP Pathway
por: Zhang, Zhenzhen, et al.
Publicado: (2023)

NOX4: a potential therapeutic target for pancreatic cancer and its mechanism
por: Bi, Yawei, et al.
Publicado: (2021)

Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer
por: Lin, Xiao-Lu, et al.
Publicado: (2017)

SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production
por: Dou, Changwei, et al.
Publicado: (2019)

Efficacy and Safety of Anti-HER2 Targeted Therapy for Metastatic HR-Positive and HER2-Positive Breast Cancer: A Bayesian Network Meta-Analysis
por: Wu, Xian-Meng, et al.
Publicado: (2023)

NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7
por: Banskota, Suhrid, et al.
Publicado: (2015)

NOX as a Therapeutic Target in Liver Disease
por: Matuz-Mares, Deyamira, et al.
Publicado: (2022)

miR-196a Upregulation Contributes to Gefitinib Resistance through Inhibiting GLTP Expression
por: Liu, Bing-Jie, et al.
Publicado: (2022)

Predictive significance of STK17A in patients with gastric cancer and association with gastric cancer cell proliferation and migration
por: Wang, Zehua, et al.
Publicado: (2021)

Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis
por: Fu, Ling-jie, et al.
Publicado: (2013)

HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients
por: Qin, Tao, et al.
Publicado: (2013)

CRISPR/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity
por: Prior, Kim-Kristin, et al.
Publicado: (2016)

NOX2-mediated reactive oxygen species are double-edged swords in focal cerebral ischemia in mice
por: Yingze, Ye, et al.
Publicado: (2022)

Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
por: Hanley, Christopher J, et al.
Publicado: (2017)

IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer
por: Wen, Yi-Yang, et al.
Publicado: (2017)

Nox4 as a novel therapeutic target for diabetic vascular complications
por: Wang, Dongxia, et al.
Publicado: (2023)

An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index
por: Hui, Xiwu, et al.
Publicado: (2022)

Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population
por: Chen, Ruixian, et al.
Publicado: (2022)

The application of HER2 and CD47 CAR-macrophage in ovarian cancer
por: Chen, Yizhao, et al.
Publicado: (2023)

Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy
por: Li, Lanyu, et al.
Publicado: (2021)

C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
por: Li, Wei, et al.
Publicado: (2018)

Nox
por: Hettche, Thomas, 1964-
Publicado: (1996)

Metformin inhibits ovarian granular cell pyroptosis through the miR-670-3p/NOX2/ROS pathway
por: Zhou, Li-Hua, et al.
Publicado: (2023)

Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft
por: Zhang, Anli, et al.
Publicado: (2010)

Retraction Note: Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis
por: Fu, Ling-jie, et al.
Publicado: (2015)

Understanding the biology of HER3 receptor as a therapeutic target in human cancer
por: Lyu, Hui, et al.
Publicado: (2018)

siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells
por: Yuan, Heng-Heng, et al.
Publicado: (2017)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice
por: Moe, K T, et al.
Publicado: (2011)

Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells
por: Li, Juan, et al.
Publicado: (2015)

Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
por: Fong, Miranda Y., et al.
Publicado: (2012)

Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer
por: Li, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6v3qsbkonp7vcj4pi56101pbdc